Skip to content

VIRPAX PHARMACEUTICALS, INC.: filings

Every VIRPAX PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 16 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2025-03-03fiscal FY 202427540001731122-25-000316
10-Q2024-11-14fiscal Q3 202427880001731122-24-001812
10-Q2024-08-12fiscal Q2 202425760001213900-24-067700
10-Q2024-05-13fiscal Q1 202424510001213900-24-042284
10-K2024-03-26fiscal FY 202323480001213900-24-025781
10-Q2023-12-07fiscal Q3 202322780001213900-23-093897
10-Q2023-08-14fiscal Q2 202322720001213900-23-066566
10-Q2023-05-12fiscal Q1 202322480001213900-23-039029
10-K2023-03-22fiscal FY 202228540001213900-23-022071
10-Q2022-11-09fiscal Q3 202227830001213900-22-070597
10-Q2022-08-15fiscal Q2 202226780001213900-22-048047
10-Q2022-05-16fiscal Q1 202224490001213900-22-027105
10-K2022-03-31fiscal FY 202127530001213900-22-016740
10-Q2021-11-15fiscal Q3 202126760001213900-21-059338
10-Q2021-08-10fiscal Q2 202127750001213900-21-041163
10-Q2021-05-17fiscal Q1 202125510001213900-21-026971

Inspect the source

Entity
VIRPAX PHARMACEUTICALS, INC. / CIK 0001708331
Captured
2026-09-21T17:24:42.998Z
SEC response SHA-256
141bd5cea94356275b1a939f590142e1749963a9c127dfa2a65328da693fad87

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001708331.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))